ResMed Basic EPS 2010-2025 | RMD
ResMed annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- ResMed basic eps for the quarter ending March 31, 2025 was $2.49, a 22.06% increase year-over-year.
- ResMed basic eps for the twelve months ending March 31, 2025 was $8.95, a 37.27% increase year-over-year.
- ResMed annual basic eps for 2024 was $0.007B, a 13.4% increase from 2023.
- ResMed annual basic eps for 2023 was $0.006B, a 14.61% increase from 2022.
- ResMed annual basic eps for 2022 was $0.005B, a 63.3% increase from 2021.
| ResMed Annual Basic EPS | |
|---|---|
| 2024 | $6.94 |
| 2023 | $6.12 |
| 2022 | $5.34 |
| 2021 | $3.27 |
| 2020 | $4.31 |
| 2019 | $2.83 |
| 2018 | $2.21 |
| 2017 | $2.42 |
| 2016 | $2.51 |
| 2015 | $2.51 |
| 2014 | $2.44 |
| 2013 | $2.15 |
| 2012 | $1.75 |
| 2011 | $1.49 |
| 2010 | $1.26 |
| 2009 | $0.97 |
| ResMed Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $2.49 |
| 2024-12-31 | $2.35 |
| 2024-09-30 | $2.12 |
| 2024-06-30 | $1.99 |
| 2024-03-31 | $2.04 |
| 2023-12-31 | $1.42 |
| 2023-09-30 | $1.49 |
| 2023-06-30 | $1.57 |
| 2023-03-31 | $1.58 |
| 2022-12-31 | $1.53 |
| 2022-09-30 | $1.44 |
| 2022-06-30 | $1.34 |
| 2022-03-31 | $1.22 |
| 2021-12-31 | $1.38 |
| 2021-09-30 | $1.40 |
| 2021-06-30 | $1.34 |
| 2021-03-31 | $-0.54 |
| 2020-12-31 | $1.24 |
| 2020-09-30 | $1.23 |
| 2020-06-30 | $1.23 |
| 2020-03-31 | $1.13 |
| 2019-12-31 | $1.11 |
| 2019-09-30 | $0.84 |
| 2019-06-30 | $0.48 |
| 2019-03-31 | $0.74 |
| 2018-12-31 | $0.87 |
| 2018-09-30 | $0.74 |
| 2018-06-30 | $0.76 |
| 2018-03-31 | $0.77 |
| 2017-12-31 | $0.07 |
| 2017-09-30 | $0.61 |
| 2017-06-30 | $0.72 |
| 2017-03-31 | $0.62 |
| 2016-12-31 | $0.54 |
| 2016-09-30 | $0.54 |
| 2016-06-30 | $0.59 |
| 2016-03-31 | $0.65 |
| 2015-12-31 | $0.68 |
| 2015-09-30 | $0.59 |
| 2015-06-30 | $0.62 |
| 2015-03-31 | $0.65 |
| 2014-12-31 | $0.65 |
| 2014-09-30 | $0.59 |
| 2014-06-30 | $0.62 |
| 2014-03-31 | $0.64 |
| 2013-12-31 | $0.61 |
| 2013-09-30 | $0.57 |
| 2013-06-30 | $0.52 |
| 2013-03-31 | $0.59 |
| 2012-12-31 | $0.54 |
| 2012-09-30 | $0.50 |
| 2012-06-30 | $0.53 |
| 2012-03-31 | $0.45 |
| 2011-12-31 | $0.43 |
| 2011-09-30 | $0.34 |
| 2011-06-30 | $0.39 |
| 2011-03-31 | $0.35 |
| 2010-12-31 | $0.38 |
| 2010-09-30 | $0.37 |
| 2010-06-30 | $0.35 |
| 2010-03-31 | $0.32 |
| 2009-12-31 | $0.31 |
| 2009-09-30 | $0.28 |
| 2009-06-30 | $0.30 |
| 2009-03-31 | $0.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.413B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.650B | 26.61 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |